| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.265 |
Evidence |
|
| MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| STK16 |
IPI00480017 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
0.265 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.265 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
0.265 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
FNBP1 |
IPI00102670 |
0.265 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.265 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
RB1 |
RB1: Retinoblastoma-associated protein |
0.265 |
Evidence |
|
| LIMK2 |
LIMK2: LIM domain kinase 2 |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
0.265 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
0.265 |
Evidence |
|
| BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
USP34 |
USP34, KIAA0570, KIAA0729: Ubiquitin carboxyl-terminal hydrolase 34 |
0.265 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
| SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
TLK1 |
TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 |
0.265 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| MATR3 |
MATR3, KIAA0723: Matrin-3 |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
0.265 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
ALB |
ALB: Uncharacterized protein ALB |
0.265 |
Evidence |
|
| NCF4 |
NCF4, SH3PXD4: Neutrophil cytosol factor 4 |
MAP3K11 |
MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 |
0.265 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.265 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.265 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
IGFBP6 |
IGFBP6, IBP6: Insulin-like growth factor-binding protein 6 precursor |
0.265 |
Evidence |
|
| NAGPA |
NAGPA: N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase precur |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.265 |
Evidence |
|
- 
- 
-